Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 14 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-14-2024-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 14, 2024, titled "Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases